PT-141 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-08-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
Bremelanotide is a cyclic heptapeptide that binds several melanocortin receptors rather than one. In vitro assays report agonist activity at MC1R, MC3R, MC4R and MC5R, with MC4R generally treated as the subtype most relevant to sexual effects. MC4R is expressed in hypothalamic nuclei involved in appetite, energy balance and motivated behaviour, which provides a plausible route for central action. Selective MC4R agonists studied in animals produce comparable behavioural changes, supporting that interpretation.
How receptor activation translates into a change in desire is not established in detail. Proposed steps include modulation of dopaminergic signalling in reward circuits and downstream effects on autonomic tone. Human data consist mainly of clinical trials measuring self-reported outcomes rather than direct measurements of brain activity or transmitter release. The transient rise in blood pressure sometimes observed after administration is likewise reported consistently but explained only partly by known melanocortin pathways.
Melanocortin receptors form a family of five G-protein-coupled proteins, labelled MC1R through MC5R, that respond to peptides derived from pro-opiomelanocortin. Alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone are the best-known endogenous ligands. The receptors are distributed differently across tissues, so a single agonist can produce effects in the brain, skin, adrenal gland and vasculature. This distribution explains why one peptide can influence both pigmentation and motivated behaviour.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
| Property | Value | Notes |
|---|---|---|
| Primary receptor target | MC4R agonist | Subtype most often linked to behavioural effects |
| Other reported targets | MC1R, MC3R, MC5R | Activity is not selective for a single subtype |
| Endogenous ligand class | Melanocortin peptides | Alpha-MSH and ACTH act on the same family |
| Peptide architecture | Cyclic heptapeptide | Lactam bridge between the aspartate and lysine residues |
| Central action | Inferred from animal models | Not directly measured in the human brain |
Clinical development proceeded through two routes of administration. An intranasal formulation advanced first, but variable absorption and tolerability problems led to a switch to subcutaneous injection. The United States Food and Drug Administration approved the subcutaneous product in 2019 for hypoactive sexual desire disorder in premenopausal women. Marketing rights subsequently changed hands, and commercial availability has fluctuated since approval. Use in men, in postmenopausal women, and in combination with other agents remains outside the approved label.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
Identity and purity testing for this peptide typically relies on reversed-phase high-performance liquid chromatography with ultraviolet detection, reported as area-percent purity. Mass spectrometry, usually in tandem mode, confirms molecular mass and supports quantification in biological matrices. Sequence confirmation may use peptide mapping after enzymatic digestion, while nuclear magnetic resonance and circular dichroism supply supplementary structural detail. No single technique establishes identity alone, so laboratories compare retention time, mass, and fragment pattern against a verified reference standard.
The lactam ring that closes the peptide backbone improves resistance to exopeptidase attack, but the molecule stays susceptible to hydrolysis and oxidation once dissolved. Degradation accelerates with temperature, extreme pH, and light exposure, and repeated freeze-thaw cycles promote aggregation and material loss. Lyophilized powder held desiccated at or below minus twenty degrees Celsius is the common way to keep reference material. Reconstituted solutions are generally kept cold and used within a short window because their stability is far lower than that of the dry solid.
Clinical programmes in this area have relied mainly on randomised, double-blind, placebo-controlled designs in premenopausal women. Primary endpoints usually combine a validated questionnaire covering desire domains with counts of satisfying sexual events and a separate measure of distress. Reported outcomes show statistically significant but modest average improvement over placebo, with wide individual variation. Adverse events such as nausea, flushing, and headache occur frequently and can limit tolerability. Whether short-term trial gains translate into lasting change for most users is an open question.
Evidence outside the studied population is sparse. Trials have concentrated on premenopausal women with a defined diagnosis, and data for postmenopausal women, men, and people taking interacting medications remain limited. Non-prescription use of the peptide for comparable goals is widespread but is not supported by published controlled data. Observed changes in blood pressure have drawn attention to cardiovascular monitoring during use. The literature generally frames the compound as a targeted receptor agonist rather than a general libido enhancer, and basic questions about mechanism and long-term safety are unresolved.
Bremelanotide functions as an agonist at several melanocortin receptor subtypes, with the strongest functional activity reported at the MC4 subtype. MC4 receptors sit in hypothalamic circuits that influence appetite, energy balance, and components of sexual behaviour. Rodents lacking functional MC4 receptors show altered mating behaviour, which supports a role for this pathway in desire. The precise sequence of events connecting receptor activation to reported human effects remains only partly characterised. Because the same receptor family governs pigmentation and inflammatory signalling, selectivity is a recurring theme in pharmacological discussion.
Lyophilized peptide arrives as a white to off-white cake or powder and is normally held at minus twenty degrees Celsius or colder for extended periods. Short-term bench work at ambient temperature is tolerable for minutes, not hours, because the solid is hygroscopic and picks up moisture that promotes hydrolysis. Vials should stay in a desiccator or a sealed bag with desiccant, protected from light, since aromatic residues in the sequence are susceptible to photo-oxidation. Inventory records that note arrival date and storage location reduce the chance of using degraded material.
Reconstitution is usually performed with sterile water or a dilute acetic acid solution, and the choice of solvent affects both dissolution speed and final pH. Complete dissolution should be confirmed by visual inspection before any aliquot is taken, since undissolved particles can concentrate in the sampling volume. Repeated freeze-thaw cycles are the most common cause of gradual loss of purity, so dividing a stock into single-use aliquots at the first opportunity is standard practice. Working solutions kept refrigerated are generally used within days rather than weeks.
Identity and purity are established with orthogonal methods rather than a single test. Reverse-phase high-performance liquid chromatography with ultraviolet detection gives a purity figure by area normalization, while mass spectrometry confirms the expected molecular ion. Amino acid analysis or peptide mapping can detect sequence errors that a mass value alone would miss, and residual counterion content is sometimes measured separately. Common impurities include truncated sequences, oxidized residues, and deamidated products; reporting them individually is more informative than a single composite purity number.
== External links == "FDA revises label of diabetes drug canagliflozin". U.S. Food and Drug Administration (FDA). 15 January 2016. Archived from the original on 13 December 2019. "FDA Drug Safety Communication: FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR)". U.S. Food and Drug Administration (FDA). 18 May 2016. "FDA Drug Safety Communication: Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate". U.S. Food and Drug Administration (FDA). 9 May 2017. Archived from the original on 1 October 2019. "Warning use metformin in certain patients with reduced kidney function". U.S. Food and Drug Administration (FDA). 14 November 2017. Archived from the original on 1 October 2019. "Warning: infection of genital area with SGLT2 inhibitors for diabetes". U.S. Food and Drug Administration (FDA). 7 September 2018.
== Special Operations units == The People's Armed Police maintains several Special Operations Units, also known by Western sources as "Special Police units". They were established in Beijing in early 1980s and in 1983 the first of them was transferred to the People's Armed Police as the People's Armed Police Special Police Group. In 1985 the Group became People's Armed Police Special Police School and, in 2002, it became the People's Armed Police Special Police Academy. In 2002, the Snow Wolf Commando Unit, since 2007 Snow Leopard Commando Unit, was established in Beijing as the second special police unit. According to Joel Wuthnow, the Snow Leopard Commando Unit was moved from the Beijing Corps to the 2nd Mobile Corps in 2018. The special operations units are tasked to carry out counter terrorism missions, riot control, anti-hijacking and bomb disposal. Local special operations units receive Explosive Ordinance Disposal (EOD) training, fast roping, counterinsurgency tactics, along with training in hostage rescue and hostage negotiation.
=== Cellular uptake mechanisms === After nanogels exit the vasculature, they diffuse through the interstitial space into their target tissue. At the cellular level, nanogels can be internalized by a large number of different types of endocytosis that depend on the particle's size, shape, and surface properties. Endocytosis is the most common mechanism that starts with the nanogels engulfed by the cellular membrane. The nanogels are transported in intracellular vesicles for delivery to endosomes that eventually combine with lysosomes. Once lysosomes are released into the cytosol of a cell, they deliver their cargo immediately or move to the appropriate cellular compartment.
It has also been posited that in the region beyond A > 300, an entire "continent of stability" consisting of a hypothetical phase of stable quark matter, comprising freely flowing up and down quarks rather than quarks bound into protons and neutrons, may exist. Such a form of matter is theorized to be a ground state of baryonic matter with a greater binding energy per baryon than nuclear matter, favoring the decay of nuclear matter beyond this mass threshold into quark matter. If this state of matter exists, it could possibly be synthesized in the same fusion reactions leading to normal superheavy nuclei, and would be stabilized against fission as a consequence of its stronger binding that is enough to overcome Coulomb repulsion.
ACS Applied Materials & Interfaces. 16 (12): 14633–14644. Bibcode:2024AAMI...1614633K. doi:10.1021/acsami.4c02243. PMC 10982941. PMID 38483312. Karki, Sandeep; Malhotra, Sahil; Ijaz, Muhammad; Rollet, Nicolas; O'Cearbhaill, Eoin D.; Bini, Estela; Brayden, David J. (2026). "A pullulan-based bilayer film for buccal delivery of a GLP-1 peptide analogue". Carbohydrate Polymers. 380 125064. doi:10.1016/j.carbpol.2026.125064. PMID 41831981.
Sources: en.wikipedia.org
Most classical force fields implicitly include the effect of polarizability, e.g., by scaling up the partial charges obtained from quantum chemical calculations. These partial charges are stationary with respect to the mass of the atom. But molecular dynamics simulations can explicitly model polarizability with the introduction of induced dipoles through different methods, such as Drude particles or fluctuating charges. This allows for a dynamic redistribution of charge between atoms which responds to the local chemical environment. For many years, polarizable MD simulations have been touted as the next generation. For homogenous liquids such as water, increased accuracy has been achieved through the inclusion of polarizability. Some promising results have also been achieved for proteins. However, it is still uncertain how to best approximate polarizability in a simulation. The point becomes more important when a particle experiences different environments during its simulation trajectory, e.g. translocation of a drug through a cell membrane.
=== EC 1.4.1 With NAD+ or NADP+ as acceptor === EC 1.4.1.1: alanine dehydrogenase EC 1.4.1.2: glutamate dehydrogenase EC 1.4.1.3: glutamate dehydrogenase (NAD(P)+) EC 1.4.1.4: glutamate dehydrogenase (NADP+) EC 1.4.1.5: L-amino-acid dehydrogenase EC 1.4.1.6: deleted, Now included with EC 1.21.4.1, D-proline reductase (dithiol) EC 1.4.1.7: serine 2-dehydrogenase EC 1.4.1.8: valine dehydrogenase (NADP+) EC 1.4.1.9: leucine dehydrogenase EC 1.4.1.10: glycine dehydrogenase EC 1.4.1.11: L-erythro-3,5-diaminohexanoate dehydrogenase EC 1.4.1.12: 2,4-diaminopentanoate dehydrogenase EC 1.4.1.13: glutamate synthase (NADPH) EC 1.4.1.14: glutamate synthase (NADH) EC 1.4.1.15: lysine dehydrogenase EC 1.4.1.16: diaminopimelate dehydrogenase EC 1.4.1.17: N-methylalanine dehydrogenase EC 1.4.1.18: lysine 6-dehydrogenase EC 1.4.1.19: tryptophan dehydrogenase EC 1.4.1.20: phenylalanine dehydrogenase EC 1.4.1.21: aspartate dehydrogenase EC 1.4.1.22: there is no overall consumption of NAD+ during the reaction. As a result, transfer of the enzyme from EC 4.3.1.12 was not necessary and EC 1.4.1.22 was withdrawn before being made official EC 1.4.1.23: valine dehydrogenase (NAD+) EC 1.4.1.24: 3-dehydroquinate synthase II EC 1.4.1.25: L-arginine dehydrogenase EC 1.4.1.26: 2,4-diaminopentanoate dehydrogenase (NAD+) EC 1.4.1.27: glycine cleavage system
Ancient habitation areas, longhouses, crop terraces, roads as the Inca road system, cemeteries, hypogeums and necropolises are all part of the architectural heritage of indigenous peoples. Some prominent indigenous structures are the preceramic and ceramic archaeological site of Tequendama, Tierradentro (a park that contains the largest concentration of pre-Columbian monumental shaft tombs with side chambers), the largest collection of religious monuments and megalithic sculptures in South America, located in San Agustín, Huila, Lost city (an archaeological site with a series of terraces carved into the mountainside, a net of tiled roads, and several circular plazas), and the large villages mainly built with stone, wood, cane, and mud. Architecture during the period of conquest and colonization is mainly derived of adapting European styles to local conditions, and Spanish influence, especially Andalusian and Extremaduran, can be easily seen. When Europeans founded cities two things were making simultaneously: the dimensioning of geometrical space (town square, street), and the location of a tangible point of orientation. The construction of forts was common throughout the Caribbean and in some cities of the interior, because of the dangers posed to Spanish colonial settlements from English, French and Dutch pirates and hostile indigenous groups. Churches, chapels, schools, and hospitals belonging to religious orders have a great urban influence. Baroque architecture is used in military buildings and public spaces.
==== Endothelial keratoplasty ==== Endothelial keratoplasty replaces the patient's endothelium with a transplanted disc of posterior stroma/Descemets/endothelium (DSEK) or Descemets/endothelium (DMEK). This relatively new procedure has revolutionized treatment of disorders of the innermost layer of the cornea (endothelium). Unlike a full-thickness corneal transplant, the surgery can be performed with one or no sutures. Patients may recover functional vision in days to weeks, as opposed to up to a year with full thickness transplants. However, an Australian study has shown that despite its benefits, the loss of endothelial cells that maintain transparency is much higher in DSEK compared to a full-thickness corneal transplant. The reason may be greater tissue manipulation during surgery, the study concluded. During surgery the patient's corneal endothelium is removed and replaced with donor tissue. With DSEK, the donor includes a thin layer of stroma, as well as endothelium, and is commonly 100–150 μm thick. With DMEK, only the endothelium is transplanted. In the immediate postoperative period the donor tissue is held in position with an air bubble placed inside the eye (the anterior chamber). The tissue self-adheres in a short period and the air is adsorbed into the surrounding tissues. Complications include displacement of the donor tissue requiring repositioning ("refloating"). This is more common with DMEK than DSEK. Folds in the donor tissue may reduce the quality of vision, requiring repair. Rejection of the donor tissue may require repeating the procedure.
Sources: en.wikipedia.org
Cell surface receptors play an essential role in the biological systems of single- and multi-cellular organisms and malfunction or damage to these proteins is associated with cancer, heart disease, and asthma. These trans-membrane receptors are able to transmit information from outside the cell to the inside because they change conformation when a specific ligand binds to it. There are three major types: Ion channel linked receptors, G protein–coupled receptors, and enzyme-linked receptors.
The Mareth Line constituted one of two fronts in the Tunisia Campaign, the second being to the north-west, where the British First Army and American II Corps, firmly established in formerly Vichy-held Morocco and Algeria following Operation Torch in November 1942, were gradually pushing the Axis forces under Hans-Jürgen von Arnim back towards Tunis. After von Arnim won a decisive victory over the Americans at the Battle of Sidi Bou Zid in mid-February 1943, destroying over 100 US tanks, the Eighteenth Army Group was formed under the British General Harold Alexander to co-ordinate the actions of the Allied forces on both Tunisian fronts. The Eighth Army under Montgomery spent February at Medinine in south-eastern Tunisia. Expecting an imminent attack by the Axis, the Eighth Army mustered every anti-tank gun it could from Egypt and Libya. The 102nd (Northumberland Hussars) Anti-Tank Regiment, including the Rhodesian Anti-Tank Battery under Major Savory, duly advanced west from Benghazi and reached the front on 5 March 1943. The Germans and Italians assaulted Medinine the next day, but failed to make much progress and abandoned their attack by the evening. The Rhodesian gunners, held in reserve, did not take part in the engagement but were attacked from the air. The Rhodesians of the KRRC, now under the 7th Motor Brigade, moved up from Libya during early March. No. 237 (Rhodesia) Squadron, which had spent 1942 and the first months of 1943 in Iran and Iraq, returned to North Africa the same month, with the future Prime Minister Ian Smith in its ranks as a Hurricane pilot.
== Early life and education == Abdel Fattah al-Burhan was born in 1960 in the village of Gandatu in northern Sudan, to a Ja'ali family. Al-Burhan studied elementary and intermediate level in his village school, and later moved to Shendi to complete his education before joining the Sudanese Military College.
Sources: en.wikipedia.org
Bremelanotide binds several melanocortin receptors, and MC4R is the subtype most often cited as responsible for its behavioural effects. Activity at MC1R, MC3R and MC5R is also reported. Selectivity is therefore described as limited rather than precise.
It is not classified as a vasodilator, and its proposed site of action is the central nervous system rather than peripheral vessels. Some trial participants show small transient blood pressure changes. Whether those changes arise centrally or through another route remains an open question.
Most evidence comes from animal models and from indirect human outcomes such as self-reported desire. Direct measurements of receptor occupancy or signalling in the human brain are not available. Published reviews therefore present a plausible pathway rather than a confirmed sequence of events.
It is a synthetic cyclic peptide that activates melanocortin receptors. It is given by injection and was approved in the United States in 2019 for a specific low-desire diagnosis in premenopausal women. It is not a hormonal therapy.